miR-433 Inhibits Glioblastoma Progression by Suppressing the PI3K/Akt Signaling Pathway Through Direct Targeting of ERBB4
OMICS: A Journal of Integrative Biology · 2023
DOI: 10.1089/omi.2023.0046 ↗Kurz gefasst
Fachartikel in der Zeitschrift OMICS: A Journal of Integrative Biology, 2023. Verfasst von Huawei Jiang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology (Cancer Institute, Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education, Key Laborator…. Hauptthemen laut MEDLINE: Glioblastoma, MicroRNAs, Glioma, Brain Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 28 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hematology (Cancer Institute, Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education, Key Laboratory of Molecular Biology in Medical Sciences), The Second Affiliated Hos…
- Department of Medical Oncology, Zhejiang Hospital, Hangzhou, China.
- Cancer Institute (Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education), The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
- Zhejiang-California International Nanosystems Institute (ZCNI) Proprium Research Center, Zhejiang University, Hangzhou, China.
- Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
- Department of Urology, University of Washington School of Medicine, Seattle, Washington, USA.
ORCID-Profile: Biaoyang Lin
Zitieren
APA
Jiang, H., Su, Z., Hu, W., Yuan, X., Yu, T., Yang, J., Xiao, X., Zheng, S., & Lin, B. (2023). miR-433 Inhibits Glioblastoma Progression by Suppressing the PI3K/Akt Signaling Pathway Through Direct Targeting of ERBB4. OMICS: A Journal of Integrative Biology. https://doi.org/10.1089/omi.2023.0046
Vancouver
Jiang H, Su Z, Hu W, Yuan X, Yu T, Yang J, et al. miR-433 Inhibits Glioblastoma Progression by Suppressing the PI3K/Akt Signaling Pathway Through Direct Targeting of ERBB4. OMICS: A Journal of Integrative Biology. 2023. doi:10.1089/omi.2023.0046
BibTeX
@article{Jiang2023,
author = {Jiang, Huawei and Su, Zhiwei and Hu, Wangxiong and Yuan, Xianggui and Yu, Teng and Yang, Jing and Xiao, Xibin and Zheng, Shu and Lin, Biaoyang},
title = {miR-433 Inhibits Glioblastoma Progression by Suppressing the PI3K/Akt Signaling Pathway Through Direct Targeting of ERBB4},
journal = {OMICS: A Journal of Integrative Biology},
year = {2023},
doi = {10.1089/omi.2023.0046}
}
EUVIMED